Literature DB >> 19896823

Engineering organs.

Anthony Atala1.   

Abstract

Applications of regenerative medicine technology may offer novel therapies for patients with injuries, end-stage organ failure, or other clinical problems. Currently, patients suffering from diseased and injured organs can be treated with transplanted organs. However, there is a severe shortage of donor organs that is worsening yearly as the population ages and new cases of organ failure increase. Scientists in the field of regenerative medicine and tissue engineering are now applying the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. The stem cell field is also advancing rapidly, opening new avenues for this type of therapy. For example, therapeutic cloning and cellular reprogramming may one day provide a potentially limitless source of cells for tissue engineering applications. Although stem cells are still in the research phase, some therapies arising from tissue engineering endeavors have already entered the clinical setting successfully, indicating the promise regenerative medicine holds for the future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896823     DOI: 10.1016/j.copbio.2009.10.003

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  58 in total

Review 1.  Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues.

Authors:  Hassan Abdulrazzak; Dafni Moschidou; Gemma Jones; Pascale V Guillot
Journal:  J R Soc Interface       Date:  2010-08-25       Impact factor: 4.118

Review 2.  Strategies for organ level tissue engineering.

Authors:  Kristine C Rustad; Michael Sorkin; Benjamin Levi; Michael T Longaker; Geoffrey C Gurtner
Journal:  Organogenesis       Date:  2010 Jul-Sep       Impact factor: 2.500

3.  The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering.

Authors:  Hongzhi Zhou; Hockin H K Xu
Journal:  Biomaterials       Date:  2011-07-14       Impact factor: 12.479

4.  Phenotypic changes in cultured smooth muscle cells: limitation or opportunity for tissue engineering of hollow organs?

Authors:  Alexander Huber; Stephen F Badylak
Journal:  J Tissue Eng Regen Med       Date:  2011-07-14       Impact factor: 3.963

Review 5.  Engineering functional epithelium for regenerative medicine and in vitro organ models: a review.

Authors:  Nihal E Vrana; Philippe Lavalle; Mehmet R Dokmeci; Fariba Dehghani; Amir M Ghaemmaghami; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2013-08-09       Impact factor: 6.389

6.  Controlling collagen fiber microstructure in three-dimensional hydrogels using ultrasound.

Authors:  Kelley A Garvin; Jacob VanderBurgh; Denise C Hocking; Diane Dalecki
Journal:  J Acoust Soc Am       Date:  2013-08       Impact factor: 1.840

7.  Characterization of dental epithelial stem cells from the mouse incisor with two-dimensional and three-dimensional platforms.

Authors:  Miquella G Chavez; Wenli Yu; Brian Biehs; Hidemitsu Harada; Malcolm L Snead; Janice S Lee; Tejal A Desai; Ophir D Klein
Journal:  Tissue Eng Part C Methods       Date:  2012-08-16       Impact factor: 3.056

8.  Gas-foaming calcium phosphate cement scaffold encapsulating human umbilical cord stem cells.

Authors:  Wenchuan Chen; Hongzhi Zhou; Minghui Tang; Michael D Weir; Chongyun Bao; Hockin H K Xu
Journal:  Tissue Eng Part A       Date:  2011-12-09       Impact factor: 3.845

Review 9.  Cellular and morphological aspects of fibrodysplasia ossificans progressiva. Lessons of formation, repair, and bone bioengineering.

Authors:  Anderson Martelli; Arnaldo Rodrigues Santos
Journal:  Organogenesis       Date:  2014-10-31       Impact factor: 2.500

Review 10.  Endometrial regeneration and endometrial stem/progenitor cells.

Authors:  Caroline E Gargett; Hong P T Nguyen; Louie Ye
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.